United States Flowable Hemostats Market to hit US$457.48 Million by 2032 | Major Companies 2026 - Aegis Lifesciences, Baxter, Teleflex Incorporated

Leander, Texas and Tokyo, Japan - Jan.13.2026
As per DataM intelligence research report "The Global Flowable Hemostats Market reached US$825.16 million in 2024 and is expected to reach US$1524.96 million by 2032, growing at a CAGR of 7.0% during the forecast period 2025-2032"

The flowable hemostats market is gaining traction due to innovations in surgical adhesives and biomaterials that improve hemostasis efficiency. Advanced delivery systems and bioactive formulations enhance patient safety and reduce procedure times. Rising surgical procedures and minimally invasive techniques are driving market growth.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/flowable-hemostats-market?prasad

Flowable Hemostats Market: Competitive Intelligence
Aegis Lifesciences, Baxter, Teleflex Incorporated, Becton, Dickinson, and Company, Johnson & Johnson Services, Inc., Pfizer Inc., 3-D Matrix Medical Technology, Medcura, Ferrosan Medical Devices A/S and Delta Surgical among others.

In the Flowable Hemostats Market, Aegis Lifesciences, Baxter, Teleflex Incorporated, Becton, Dickinson, and Company (BD), Johnson & Johnson Services, Inc., Pfizer Inc., 3‐D Matrix Medical Technology, and Medcura collectively reinforce a landscape defined by procedural safety, surgical efficiency, and improved patient outcomes. These companies supply clinically validated flowable hemostatic agents and delivery systems that help surgeons control bleeding quickly in complex and minimally invasive procedures-supporting better recovery times and reduced complication rates. Their broad portfolios address diverse clinical needs across specialties such as trauma, cardiovascular, orthopedics, and general surgery, enabling adoption by hospitals and surgical centers globally. By aligning product performance with evolving clinical guidelines and healthcare quality metrics, they support procedural standardization and institutional risk management. Together, they strengthen the Flowable Hemostats Market's role in enhancing surgical care delivery and improving health system value.

Individually and in synergy, these firms' capabilities enhance competitive differentiation and innovation within the Flowable Hemostats Market by blending deep clinical expertise, robust regulatory compliance, and targeted product development. Aegis Lifesciences and Medcura offer specialized formulations and delivery systems tailored to surgeon preferences for rapid hemostasis in challenging operative environments. Baxter and Teleflex contribute established hemostatic portfolios with strong distribution channels that support consistent availability for acute care settings. BD and Johnson & Johnson bring comprehensive surgical care ecosystems that integrate flowable hemostats with complementary devices and clinician support programs, reinforcing adoption in high‐volume procedures. Pfizer's involvement adds scale and scientific rigor, enhancing product confidence in key markets. 3‐D Matrix Medical Technology's focus on precision hemostatic matrices and catheter‐compatible systems complements these strengths by addressing minimally invasive applications and niche procedural demands. Together, this group drives market momentum through innovation, clinical relevance, and global reach-elevating the Flowable Hemostats Market's capacity to meet the needs of modern surgical practice.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/flowable-hemostats-market?prasad

United States: Recent Industry Developments

✅ In January 2026, Johnson & Johnson launched new flowable hemostats with automated delivery systems, improving surgical efficiency, accelerating clotting times, and integrating real-time monitoring to reduce intraoperative bleeding risk.

✅ In November 2025, Medtronic invested $65 million to scale production of flowable hemostats with automated dispensing technology, enhancing surgical precision, reducing preparation time, and standardizing application during procedures.

✅ In August 2025, hospitals adopted automated flowable hemostat delivery systems that reduce manual handling, improve application consistency, and integrate with operating room tracking systems for better surgical workflow.

✅ In June 2025, startups introduced AI-assisted flowable hemostat platforms capable of automated mixing, real-time flow control, and surgical procedure integration to optimize performance and safety.

Japan: Recent Industry Developments

✅ In January 2026, Terumo Corporation deployed AI-integrated flowable hemostats in surgical suites, supported by $20 million investment, enabling automated dispensing, enhanced clotting efficiency, and streamlined operating room workflow.

✅ In October 2025, Nipro Corporation implemented automated flowable hemostat delivery systems with real-time monitoring to reduce surgical bleeding risk, improve precision, and enhance patient safety.

✅ In July 2025, hospitals in Japan introduced robotic-assisted hemostat application systems, integrating flowable hemostats with automated delivery and monitoring to optimize surgical outcomes.

✅ In April 2025, Japanese research institutes tested AI-assisted flowable hemostats with automated control systems for surgical simulations, improving reproducibility, performance, and operative efficiency.

Segment Covered in the Flowable Hemostats Market:
By Product
The market is segmented into active hemostats 45%, combination hemostats 35%, and passive hemostats 20%. Active hemostats lead due to their rapid clotting ability in high-bleeding surgical procedures. Combination hemostats are gaining strong traction as they integrate mechanical matrices with biologically active agents, offering superior efficacy across complex surgeries.

By Material
Based on material, the market includes porcine gelatin 60% and bovine gelatin 40%. Porcine gelatin dominates owing to its high biocompatibility, superior absorption characteristics, and widespread regulatory acceptance. Bovine gelatin continues to be used extensively due to cost advantages and established clinical usage.

By Application
Applications include general surgery 35%, cardiovascular surgery 30%, orthopedic surgery 25%, and others 10%. General surgery holds the largest share due to the high volume of procedures globally. Cardiovascular and orthopedic surgeries contribute significantly because of the need for precise bleeding control in complex and minimally invasive interventions.

By End-User
End-users comprise hospitals 70%, clinics 15%, diagnostic laboratories 10%, and others 5%. Hospitals dominate as they perform a wide range of surgical procedures requiring advanced hemostatic solutions. Clinics are increasingly adopting flowable hemostats with the growth of outpatient and minimally invasive surgeries.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=flowable-hemostats-market

Regional Analysis
North America - 38% Share
North America leads with strong adoption of advanced surgical products, high surgical procedure volumes, and the presence of major medical device manufacturers, particularly in the U.S.

Europe - 27% Share
Europe accounts for a significant share driven by rising surgical volumes, strong reimbursement frameworks, and increasing use of advanced hemostatic agents in cardiovascular and orthopedic surgeries.

Asia-Pacific - 22% Share
Asia-Pacific is the fastest-growing region due to expanding healthcare infrastructure, increasing surgical procedures, and rising awareness of advanced wound management solutions in countries such as China, India, and Japan.

South America - 8% Share
South America shows steady growth supported by improving healthcare access, increasing hospital investments, and rising adoption of modern surgical technologies in Brazil and Argentina.

Middle East & Africa - 5% Share
Middle East & Africa holds a smaller share but is growing with increasing healthcare investments, hospital modernization initiatives, and rising surgical demand across GCC countries and South Africa.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.